What is KRTL's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for KRTL?

P/E (TTM) is n/a and 52-week range is $0.01 to $0.15 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s KRTL figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Where is KRTL Holding Group Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Lakewood, Colorado, US, 74.1M shares outstanding, ISIN US74823U1034 when available from company profile and filing metadata.

KRTL Holding Group Inc

$KRTL

Health Care · Pharmaceuticals

Run Scenarios

Browse other companiesFree AI scores and summaries for more stocks

KRTL Holding Group Inc

$KRTL

Health Care · Pharmaceuticals

Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

KRTL Holding Group, Inc. manufactures and distributes water. The company is headquartered in Lakewood, Colorado. The company went IPO on 2001-06-21. The firm operates through its subsidiaries, including KRTL Biotech, Inc., KRTL International Corp and Neurogen Brain Balancing, LLC (Neurogen). KRTL Biotech, Inc. is a pharmaceutical company focused on the commercialization of APIs and licensing agreements within the pharmaceutical and nutraceutical sectors. KRTL Biotech, Inc. focuses on biotechnology, particularly in securing and developing global partnerships for the sourcing and distribution of critical APIs and wellness-focused compounds. KRTL International Corp focuses on bridging global markets through international consulting, trade and distribution of advanced bio and agri-technologies and services. Neurogen is a neurotechnology company focused on advanced brain balancing therapies and personalized cognitive optimization systems.

Website

www.krtlholding.com/

IPO

2001-06-21

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

OTC MARKETS

ISIN

US74823U1034

Headquarters

Lakewood, Colorado, US

Shares outstanding

74.1M

NAICS sector

Manufacturing

Browse other companiesFree AI scores and summaries for more stocks

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

KRTL Holding Group, Inc. manufactures and distributes water. The company is headquartered in Lakewood, Colorado. The company went IPO on 2001-06-21. The firm operates through its subsidiaries, including KRTL Biotech, Inc., KRTL International Corp and Neurogen Brain Balancing, LLC (Neurogen). KRTL Biotech, Inc. is a pharmaceutical company focused on the commercialization of APIs and licensing agreements within the pharmaceutical and nutraceutical sectors. KRTL Biotech, Inc. focuses on biotechnology, particularly in securing and developing global partnerships for the sourcing and distribution of critical APIs and wellness-focused compounds. KRTL International Corp focuses on bridging global markets through international consulting, trade and distribution of advanced bio and agri-technologies and services. Neurogen is a neurotechnology company focused on advanced brain balancing therapies and personalized cognitive optimization systems.

Website

www.krtlholding.com/

IPO

2001-06-21

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)